FormDSignal

Kiniksa Pharmaceuticals International, plc (KNSA)

1 Item 5.02 filing since 2026-10-22 · roles: COO. Nasdaq. Pharmaceutical Preparations.

ScoreFiledEventRolePersonSeatSummary
602026-10-22AppointmentCOOsubscribers—Kiniksa Pharmaceuticals International, plc (KNSA): COO Ross Moat appointed

Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works